Elagolix Sodium and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Elagolix Sodium and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: elagolix
Brand name: Orilissa
Synonyms: Elagolix
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elagolix Sodium-Insulin degludec
- Elagolix Sodium-Insulin Degludec (U-100) Prefilled Pens
- Elagolix Sodium-Insulin Degludec (U-100) Vials
- Elagolix Sodium-Insulin Degludec (U-200) Prefilled Pens
- Elagolix Sodium-Insulin degludec and liraglutide
- Elagolix Sodium-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Elavil
- Insulin aspart, recombinant Subcutaneous-Elbasvir and grazoprevir
- Insulin aspart, recombinant Subcutaneous-Eldepryl
- Insulin aspart, recombinant Subcutaneous-Eldepryl Capsules
- Insulin aspart, recombinant Subcutaneous-Eldepryl Oral
- Insulin aspart, recombinant Subcutaneous-Eldepryl Tablets